• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC in the Press, December 2, 2016


A review of our peer-reviewed research in the healthcare and mainstream press.

The Patient Engagement HIT website featured an article on a recent American Journal of Managed Care (AJMC) study, “Enhancing Patient and Family Engagement Through Meaningful Use Stage 3: Opportunities and Barriers to Implementation.” It discussed the study’s argument that healthcare industry stakeholders and CMS should consider modifications to the patient engagement requirements as the optional reporting period for Stage 3 Meaningful Use approaches.

Care of Adults with Chronic Childhood Conditions, a guidebook published by Springer, cited an AJMC study in the chapter “Adherence and Self-Management.” The cited study discussed how text messaging could be used for chronic disease management.

MedPage Today published a compilation of cardiology news items that included an article from AJMC’s coverage of the 2016 meeting of the American College of Rheumatology. The article discussed a new study presented at the meeting suggesting that “a test used to predict future disease activity in patients with rheumatoid arthritis (RA) might someday tell physicians which patients are at risk for cardiovascular events, such as heart attacks or coronary infection.”

An article in BMC Public Health, “Healthy and Productive Workers: Using Intervention Mapping to Design a Workplace Health Promotion and Wellness Program to Improve Presenteeism,” referenced an AJMC study. That study, “A Systematic Review of Measurement Properties of Instruments Assessing Presenteeism,” examined the relative value of instruments that measure presenteeism (decreased productivity while at work).

Related Videos
Video 2 - "Adverse Events & Existing Treatment Options for Dry Eye Disease"
Overview of Dry Eye Disease (DED) Causes and Treatments
Video 12 - "Harnessing Indication-Specific Data on Biosimilars"
Video 11 - "An Overview of Biosimilar Extrapolation During FDA Approval"
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Related Content
© 2023 MJH Life Sciences
All rights reserved.